Question 1

Does Adage Capital Partners GP own OCUL stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Adage Capital Partners GP holds 1,550,000 shares of OCUL (Ocular Therapeutix), worth $15.2M.

Question 2

How many shares of OCUL does Adage Capital Partners GP own?

Accepted Answer

As of its Q2 2026 13F, Adage Capital Partners GP holds 1,550,000 shares of OCUL (Ocular Therapeutix).

Question 3

What is Adage Capital Partners GP's OCUL position worth?

Accepted Answer

As of its Q2 2026 13F, Adage Capital Partners GP's OCUL position is worth $15.2M.

Question 4

Is Adage Capital Partners GP buying or selling OCUL?

Accepted Answer

In Q2 2026, Adage Capital Partners GP opened a new OCUL position of 1,550,000 shares.

Question 5

When did Adage Capital Partners GP first buy OCUL?

Accepted Answer

Adage Capital Partners GP first reported OCUL in its Q1 2024 13F and has listed it in 9 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	New	1.6M	-	$15.2M	0.0%	$9.82	39
2026-Q1	Exited	0	-100.0%	$0	0.0%	$8.47	0
2025-Q4	Increased	4.6M	+15.5%	$56.1M	0.1%	$12.14	34
2025-Q3	Increased	4M	+2.9%	$46.8M	0.1%	$11.69	30
2025-Q2	Decreased	3.9M	-25.2%	$36.1M	0.1%	$9.28	0
2025-Q1	Increased	5.2M	+44.4%	$38.1M	0.1%	$7.33	39
2024-Q4	Decreased	3.6M	-4.0%	$30.7M	0.1%	$8.54	0
2024-Q3	Increased	3.8M	+1.5%	$32.6M	0.1%	$8.70	29
2024-Q2	Increased	3.7M	+885.4%	$25.3M	0.0%	$6.84	46
2024-Q1	New	375,000	-	$3.4M	0.0%	$9.10	37

OCUL10 quarters

OCUL
10 quarters